Baseline Insulin-Like Growth Factor-I Plasma Levels, Systemic Inflammation, Weight Loss and Clinical Outcome in Metastatic Non-Small Cell Lung Cancer Patients

Publisher： Karger

E-ISSN： 1423-0232|81|2|113-118

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.2, 2011-10, pp. : 113-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage I–IV Non-Small Cell Lung Cancer Patients

By  

Respiration, Vol. 85, Iss. 2, 2012-07 ,pp. : 119-125

Karger

Access to resources Recommend Favorite

Local Expression of Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-I Receptor, and Estrogen Receptor Alpha in Ovarian Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 11, 2009-10 ,pp. : 638-644

Karger

Access to resources Recommend Favorite

Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab

By  

Oncology, Vol. 93, Iss. 1, 2017-04 ,pp. : 62-66

Karger

Access to resources Recommend Favorite

Relationship between icotinib hydrochloride exposure and clinical outcome in Chinese patients with advanced non–small cell lung cancer

By  

CANCER, Vol. 121, Iss. S17, 2015-09 ,pp. : 3146-3156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of the radical hypofractioned radiotherapy treatment in patients with stage I and II of non-small cell lung cancer

By  

Journal of Radiotherapy in Practice, Vol. 12, Iss. 2, 2012-05 ,pp. : 139-145

Cambridge University Press

Access to resources Recommend Favorite